Compare Chainbase (C) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chainbase vs Enzyme — how do they compare? Chainbase trades at Rp1,109 (market cap Rp429,46M, Rp58,52M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Chainbase is far larger — about 3.2× Enzyme's market cap, and Chainbase's supply is capped (387M / 1B C (39%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Chainbase for 10 Days and Enzyme for 29 Days on average.
| C | MLN | |
|---|---|---|
Market Cap | Rp429,46M | Rp134,13M |
Volume (24h) | Rp58,52M | Rp104,56M |
Circulating Supply | 387M / 1B C (39%) | 3,3M MLN |
Typical Hold Time | 10 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Chainbase is trading at Rp1,110.843 with a market cap of Rp427.15M, showing bullish technical signals overall. The token is currently in a strong uptrend with moving averages indicating positive momentum, though oscillators are neutral. Key resistance levels are at Rp1,258 and Rp1,298, while support sits at Rp1,151 and Rp1,084. With only 39% of the maximum 1M token supply in circulation and an average hold time of 10 days, the token shows moderate distribution and short-term holding patterns.
Overall outlook remains cautiously optimistic with strong technical momentum but overbought RSI signals suggesting potential near-term consolidation. Major opportunities include the limited token supply and bullish trend structure, while risks include high volatility from low market cap and potential profit-taking pressure given extended RSI readings. Investors should monitor key support levels for entry opportunities.
Enzyme (MLN) shows limited market activity with a market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates a relatively short hold time of 29 days, suggesting active trading patterns. Current technical positioning requires updated price data for comprehensive analysis. Recent ecosystem developments appear limited based on available information.
Overall outlook remains cautious due to limited market data and ecosystem activity. Key opportunities include potential protocol upgrades and increased adoption, while major risks involve low liquidity and market volatility. Investors should monitor on-chain metrics and exchange listings for improved visibility.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Chainbase
Chainbase is developing the Hyperdata Network for AI, establishing a foundational layer for the DataFi era. This network converts fragmented on-chain signals into structured, verifiable, and AI-ready data, facilitating seamless collaboration among agents, applications, and humans. Chainbase empowers a decentralized data economy where data is treated as capital—composable, monetizable, and accessible to everyone.
Read more on C →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
